title: Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon.
abstract: Scleroderma, a disease involving excessive collagen deposition, can be studied using fibroblasts cultured from affected tissues. We find that curcumin, the active component of the spice turmeric, causes apoptosis in scleroderma lung fibroblasts (SLF), but not in normal lung fibroblasts (NLF). This effect is likely to be linked to the fact that although curcumin induces the expression of the phase 2 detoxification enzymes heme oxygenase 1 and glutathione S-transferase P1 (GST P1) in NLF, SLF are deficient in these enzymes, particularly after curcumin treatment. The sensitivity of cells to curcumin-induced apoptosis and the expression of GST P1 (but not heme oxygenase 1) are regulated by the epsilon isoform of protein kinase C (PKCepsilon). SLF, which contain less PKCepsilon and less GST P1 than NLF, become less sensitive to curcumin-induced apoptosis and express higher levels of GST P1 when transfected with wild-type PKCepsilon, but not with dominant-negative PKCepsilon. Conversely, NLF become sensitive to curcumin-induced apoptosis and express lower levels of GST P1 when PKCepsilon expression or function is inhibited. The subcellular distribution of PKCepsilon also differs in NLF and SLF. PKCepsilon is predominantly nuclear or perinuclear in NLF but is associated with stress fibers in SLF. Just as PKCepsilon levels are lower in SLF than in NLF in vitro, PKCepsilon expression is decreased in fibrotic lung tissue in vivo. In summary, our results suggest that a signaling pathway involving PKCepsilon and phase 2 detoxification enzymes provides protection against curcumin-induced apoptosis in NLF and is defective in SLF. These observations suggest that curcumin may have therapeutic value in treating scleroderma, just as it has already been shown to protect rats from lung fibrosis induced by a variety of agents.
authors.affiliation: Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Elena
authors.initials: E
authors.lastname: Tourkina
authors.forename: Pal
authors.initials: P
authors.lastname: Gooz
authors.forename: James C
authors.initials: JC
authors.lastname: Oates
authors.forename: Anna
authors.initials: A
authors.lastname: Ludwicka-Bradley
authors.forename: Richard M
authors.initials: RM
authors.lastname: Silver
authors.forename: Stanley
authors.initials: S
authors.lastname: Hoffman
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001761:Bleomycin; D002467:Cell Nucleus / Q000201:enzymology; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D003474:Curcumin / Q000494:pharmacology* / Q000627:therapeutic use; D015536:Down-Regulation / Q000502:physiology; D004351:Drug Resistance / Q000187:drug effects / Q000502:physiology; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology*; D005982:Glutathione Transferase / Q000378:metabolism; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism; D051547:Heme Oxygenase-1; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D008297:Male; D008565:Membrane Proteins; D051379:Mice; D018384:Oxidative Stress / Q000502:physiology; D011493:Protein Kinase C / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D051744:Protein Kinase C-epsilon; D011658:Pulmonary Fibrosis / Q000201:enzymology* / Q000209:etiology / Q000473:pathology; D012595:Scleroderma, Systemic / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D015398:Signal Transduction / Q000502:physiology; D022502:Stress Fibers / Q000201:enzymology; D014162:Transfection
chemical_list: D008565:Membrane Proteins; D001761:Bleomycin; C496541:HMOX1 protein, human; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; C496542:Hmox1 protein, mouse; D005982:Glutathione Transferase; C497256:Prkce protein, mouse; C497255:PRKCE protein, human; D011493:Protein Kinase C; D051744:Protein Kinase C-epsilon; D003474:Curcumin